Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma

BACKGROUND & AIMS: The metabolic dysfunction-associated fatty liver disease (MAFLD) is a new inclusive term proposed to replace non-alcoholic fatty liver disease (NAFLD). We analysed whether hepatocellular carcinoma (HCC) risk differs by MAFLD or NAFLD status in a large sample of asymptomatic ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Byeong Geun, Choi, Sung Chul, Goh, Myung Ji, Kang, Wonseok, Sinn, Dong Hyun, Gwak, Geum-Youn, Paik, Yong-Han, Choi, Moon Seok, Lee, Joon Hyeok, Paik, Seung Woon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393797/
https://www.ncbi.nlm.nih.gov/pubmed/37538246
http://dx.doi.org/10.1016/j.jhepr.2023.100810

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393797/
https://www.ncbi.nlm.nih.gov/pubmed/37538246
http://dx.doi.org/10.1016/j.jhepr.2023.100810

Ejemplares similares